No impact of resistance-associated substitutions on the high efficacy of sofosbuvir-velpatasvir-voxilaprevir for 12 weeks in direct-acting antiviral-experienced patients: An integrated resistance analysis of the POLARIS-1 and POLARIS-4 studies